Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

Antibody 12D7 shows therapeutic efficacy against cancer in combination with chemotherapy

May 6, 2011

Humanized monoclonal antibody XGFR-4 targets two signaling pathways in cancer

May 6, 2011

Aquaporin-9 expression demonstrated in malignant glioma biopsies

May 5, 2011

Glaucoma candidate ATS-907 shows promising efficacy and safety profile

May 5, 2011

New MAb targeting anti-Muellerian hormone type-2 receptor suppresses ovarian tumors in vivo

May 5, 2011

BiTE antibody MT-112/BAY-2010112 targets prostate cancer

May 5, 2011

SYL-1001 confers analgesia in animal model of ocular pain

May 5, 2011

Hutchison MediPharma presents preclinical data on new small-molecule anticancer agents

May 5, 2011

Methamphetamine-targeted dendribodies show no toxicity in vitro

May 4, 2011

Humanized MAb NEO-201 shows preclinical promise for treatment of solid tumors

May 4, 2011

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 28, 2026.
Detecting the invisible: minimal residual disease at AACR 2026
BioWorld Science
Minimal residual disease (MRD) has become a central concept in modern oncology, reshaping how clinicians evaluate response, relapse risk and treatment precision....
News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Sichuan Kelun Pharmaceutical Research Institute discovers GPR6 inverse agonists
BioWorld Science
Sichuan Kelun Pharmaceutical Research Institute Co. Ltd. has identified G protein-coupled receptor 6 (GPR6) inverse agonists reported to be useful for the...
Grace Therapeutics hits CRL setback with GTx-104 despite positive trial
BioWorld
Grace Therapeutics Inc.’s hopes of becoming the first company in decades to update the standard of care in aneurysmal subarachnoid hemorrhage were delayed after...